Tenet Healthcare Corporation (THC) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $183.39 (+3.54%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2026 | Jason Cassorla | Guggenheim | $283.00 | +54.3% |
| Feb 16, 2026 | Stephen Baxter | Wells Fargo | $265.00 | +44.5% |
| Feb 13, 2026 | Andrew Mok | Barclays | $257.00 | +40.1% |
| Feb 12, 2026 | Matthew Gillmor | KeyBanc | $250.00 | +36.3% |
| Feb 3, 2026 | Ben Hendrix | RBC Capital | $253.00 | +38.0% |
| Dec 18, 2025 | Craig Hettenbach | Morgan Stanley | $247.00 | +34.7% |
| Nov 21, 2025 | Andrew Mok | Barclays | $240.00 | +30.9% |
| Oct 29, 2025 | Sarah James | Raymond James | $245.00 | +33.6% |
| Oct 17, 2025 | Ann Hynes | Mizuho Securities | $225.00 | +22.7% |
| Oct 14, 2025 | David MacDonald | Truist Financial | $225.00 | +22.7% |
| Oct 14, 2025 | Scott Fidel | Goldman Sachs | $224.00 | +22.1% |
| Oct 8, 2025 | Matthew Gillmor | KeyBanc | $225.00 | +22.7% |
| Oct 7, 2025 | Stephen Baxter | Wells Fargo | $238.00 | +29.8% |
| Jul 16, 2025 | David MacDonald | Truist Financial | $205.00 | +11.8% |
| Jan 7, 2025 | Matthew Gillmor | KeyBanc | $185.00 | +0.9% |
| Dec 16, 2024 | Jamie Perse | Goldman Sachs | $140.00 | -23.7% |
| Oct 29, 2024 | Justin Lake | Wolfe Research | $178.00 | -2.9% |
| Jul 26, 2024 | Ann Hynes | Mizuho Securities | $170.00 | -7.3% |
| Jul 25, 2024 | David MacDonald | Truist Financial | $170.00 | -7.3% |
| Jul 15, 2024 | David MacDonald | Truist Financial | $155.00 | -15.5% |
Top Analysts Covering THC
THC vs Sector & Market
| Metric | THC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 22 | 8 | 18 |
| Target Upside | +46.1% | +1150.2% | +14.9% |
| P/E Ratio | 9.54 | 6.86 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $21.92B | $22.01B | $22.19B | 15 |
| 2027-03-31 | $5.40B | $5.45B | $5.51B | 6 |
| 2027-06-30 | $5.43B | $5.48B | $5.54B | 6 |
| 2027-09-30 | $5.44B | $5.50B | $5.56B | 6 |
| 2027-12-31 | $5.71B | $5.77B | $5.83B | 6 |
| 2028-03-31 | $5.71B | $5.77B | $5.83B | 6 |
| 2028-06-30 | $5.75B | $5.81B | $5.87B | 5 |
| 2028-09-30 | $5.73B | $5.79B | $5.85B | 5 |
| 2028-12-31 | $6.00B | $6.06B | $6.12B | 6 |
| 2029-12-31 | $23.38B | $23.78B | $24.23B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $16.63 | $17.20 | $18.11 | 12 |
| 2027-03-31 | $4.29 | $4.34 | $4.40 | 5 |
| 2027-06-30 | $4.27 | $4.32 | $4.38 | 5 |
| 2027-09-30 | $4.11 | $4.16 | $4.22 | 5 |
| 2027-12-31 | $4.85 | $4.91 | $4.98 | 5 |
| 2028-03-31 | $4.49 | $4.55 | $4.61 | 7 |
| 2028-06-30 | $4.42 | $4.48 | $4.54 | 6 |
| 2028-09-30 | $3.81 | $3.86 | $3.91 | 6 |
| 2028-12-31 | $4.50 | $4.56 | $4.62 | 7 |
| 2029-12-31 | $23.23 | $23.74 | $24.33 | 2 |
Frequently Asked Questions
What is the analyst consensus for THC?
The consensus among 22 analysts covering Tenet Healthcare Corporation (THC) is Buy with an average price target of $258.55.
What is the highest price target for THC?
The highest price target for THC is $283.00, set by Jason Cassorla at Guggenheim on 2026-03-12.
What is the lowest price target for THC?
The lowest price target for THC is $47.00, set by Andrew Mok CFA at UBS on 2022-10-24.
How many analysts cover THC?
22 analysts have issued ratings for Tenet Healthcare Corporation in the past 12 months.
Is THC a buy or sell right now?
Based on 22 analyst ratings, THC has a consensus rating of Buy (2.00/5) with a +46.1% upside to the consensus target of $258.55.
What are the earnings estimates for THC?
Analysts estimate THC will report EPS of $17.20 for the period ending 2026-12-31, with revenue estimated at $22.01B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.